TGFß signalling is required to maintain pluripotency of human naïve pluripotent stem cells. (2021)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.7554/elife.67259
PubMed Identifier: 34463252
Publication URI: http://europepmc.org/abstract/MED/34463252
Type: Journal Article/Review
Volume: 10
Parent Publication: eLife
ISSN: 2050-084X